| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030239 |
| Receipt No. | R000034533 |
| Official scientific title of the study | Effects of kikyo-to on sore throat pain associated with acute upper respiratory tract infection: a randomized, controlled trial |
| Date of disclosure of the study information | 2017/12/04 |
| Last modified on | 2019/01/18 (Ver. 9) |
| Basic information | ||
| Official scientific title of the study | Effects of kikyo-to on sore throat pain associated with acute upper respiratory tract infection: a randomized, controlled trial | |
| Title of the study (Brief title) | Study of kikyo-to for upper respiratory tract infection (KURI) | |
| Region |
|
|
| Condition | |||
| Condition | upper respiratory tract infection | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | We investigate the efficacy of kikyo-to on sore throat pain associated with acute URTI compared with a placebo. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Primary outcome is the difference on sore throat VAS scale between 10 minutes after kikyo-to is taken. |
| Key secondary outcomes | Secondary outcomes are the proportion of patients with sore throat score more than moderate level between 10 minutes after kikyo-to is taken. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients receive 2.5g herbal extract preparation of kikyo-to, a Japanese herbal medicine, desolved with a cup of hot water. | |
| Interventions/Control_2 | Patients receive 2.5g placebo (lactose), desolved with a cup of hot water. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients of upper respiratory tract infections with a complaint of sore throat, who visited a general internal medicine department office in the Akashi medical center hospital from December 2017 to June 2018 were registered. | |||
| Key exclusion criteria | Patients with allergy to kikyo-to and lactose, patients with aldosteronism, patients with myopathy, patients with known hypokalemia, pregnant patients or patients with possibility of pregnancy, breastfeeding patients, patients who take kikyo-to, patients inurgent condition, patients who were unable to participate the study because of dementia, visual impairment and unable to answer, or complete the study form. | |||
| Target sample size | 70 | |||
| Research contact person | |
| Name of lead principal investigator | Naoto Ishimaru |
| Organization | Akashi Medical Center |
| Division name | Department of General Internal Medicine |
| Address | 743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan |
| TEL | 0789361101 |
| maru-tkb@umin.ac.jp | |
| Public contact | |
| Name of contact person | Naoto Ishimaru |
| Organization | Akashi Medical Center |
| Division name | Department of General Internal Medicine |
| Address | 743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan |
| TEL | 0789361101 |
| Homepage URL | |
| maru-tkb@umin.ac.jp | |
| Sponsor | |
| Institute | Akashi Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | AIJINKAI Healthcare Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 社会医療法人愛仁会明石医療センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034533 |